The relationship between thyroid hormones and IGF-1 after thyroidectomy
Keywords:
Total thyroidectomy; decreased IGF-1 and thyroid hormones.Abstract
Background: decreased IGF-1 and thyroid hormones are one of the major complications following total thyroidectomy that can range in severity from asymptomatic to an acute life-threatening condition. Aim of the study to evaluate the decreased IGF-1 and thyroid hormones in total thyroidectomy patients, with regard to the time periods after the operation. The design of the study included the presence of three groups of patients with different characteristics in terms of time periods after the total removal of the thyroid gland, and a fourth group is the healthy group, and each group consisted of 30 samples. Patients with cancer, diabetes, blood pressure, and pregnant women were excluded from the study, and the study was limited to patients who had thyroid gland removal operations for reasons or benign tumors. The results of this study have shown, decreased IGF-1 and thyroid hormones was different from one group to another, but all three groups were lower than the control group, where the first group was lower, then the second and third groups, which were higher than the first and second groups, and lower than the control group. Conclusion: All patients different ages and time periods after the total thyroidectomy, they were decreased IGF-1 and thyroid hormones.
Downloads
References
Bartke, A., & Brannan, S. (2023). Growth hormone. In Anti¬
Aging Pharmacology (pp. 329-339). Academic Press.
Fitzgerald, L. A., Williamson, S., Shakil, J., & Robbins, R. J. (2023).
MEN1in a Patient with No Syndromic Familial No Medullary
Thyroid Carcinoma. JCEM Case Reports,1(1), luac019.
Pereira, N. N. (2019). Factors Affecting Testicular Growth
and Development in the Beef Bull (Doctoral dissertation,
North Dakota State University).
Bremer, J., Heringstad, B., Morrell, J. M., & Kommisrud, E.
(2023). Associations between insulin-like factor 3,
scrotum circumference and semen characteristics in
young Norwegian Red bulls, animal,100713.
Dichtel, L. E., Cordoba-Chacon, J., & Kineman, R. D. (2022).
Growth hormone and insulin-like growth factor 1 regulation
of nonalcoholic fatty liver disease.The Journal of Clinical
Endocrinology & Metabolism,107(7),1812-1824.
Barranco, H., Fazendin, J., Lindeman, B., Chen, H., &
Ramonell, K. M. (2023). Thyroid hormone replacement
following lobectomy: Long-term institutional analysis 15
years after surgery. Surgery,173(1), 189-192.
Hemmati, M., Tabesh, H., Peyghambari, A., & Bazrafshan, H.
(2023). In silico dose adjustment of levothyroxine after
total thyroidectomy using fuzzy logic methodology: A
proof-of-concept study. Heliyon, e12797.
Ma, E. Z., Kuo, J. H., Malek, R., Turner, D. J., Olson Jr, J. A.,
Slejko, J. F., ... & Hu, Y. (2023). Total thyroidectomy is
more cost-effective than radioactive iodine as an
alternative to antithyroid medication for Graves'
disease. Surgery,173(1), 193-200.
Azmi, N. L, Ismail, W. F. W., & Azlan, W. M. W. M. (2023). The
Effect of Calcium Supplements on Levothyroxine after
Total Thyroidectomy: Results from a Single Centre,
Retrospective Study in Kelantan, Malaysia. Journal of
Pharmacy and Medical Sciences (IRJPMS), 6(2), 1-4.
Giorgio, S., Francesco, M., Michela, C., Cristiana, A.,
Ludovico, Q., Luca, B., ... & Clelia, C. (2023). Growth
hormone responses during arginine and clonidine
stimulation test: Correlations with patients' auxological
and metabolic parameters in a single centre
study. Growth Hormone & IGF Research, 68, 101522.
Rao, A., Laghari, A. A., Bari, I., Khalid, M. U., Kirmani, S., &
Bari, M. E. (2023). Endocrine Abnormalities in Children
with Traumatic Brain Injury at a Tertiary Care
Center. Cureus Journal of Medical Science,15(1).
Vlad, R. M., Albu, A. I., Nicolaescu, I. D., Dobritoiu, R., Carsote, M.,
Sandru, F.,... & Pacurar, D. (2023). An Approach to Traumatic
Brain Injury-Related Hypopituitarism: Overcoming the
Pediatric Challenges.Diagnostics,13(2), 212.
Chang, Y. J., Hwu, C. M., Yeh, C. C., Wang, P. S., & Wang, S.
W. (2014). Effects of subacute hypothyroidism on
metabolism and growth-related
molecules. Molecules,19(8), 11178-11195.
Seek, T., Scheidt Nave, C., Leidig Bruckner, G., Ziegler, R., &
Pfeilschifter, J. (2001). Low serum concentrations of insulin
like growth factor I are associated with femoral bone loss in
a population based sample of postmenopausal
women. Clinical endocrinology, 55(1),101-106.
Barrett Connor, E., & Goodman Gruen, D. (1998). Gender
differences in insulin like growth factor and bone mineral
density association in old age: The Rancho Bernardo
Study. Journal of Bone and Mineral Research,13(8),
-1349.
Van Varsseveld, N. C., Sohl, E., Drent, M. L., & Lips, P. (2015).
Gender-specific associations of serum insulin-like growth
factor-1 with bone health and fractures in older
persons. The Journal of Clinical Endocrinology &
Metabolism,100(11), 4272-4281.
Philippou, A., Halapas, A., Maridaki, M., & Koutsilieris, M.
(2007). Type I insulin-like growth factor receptor
signaling in skeletal muscle regeneration and hypertrophy. J Musculoskelet Neuronal Interact, 7(3),
-18.
Smith, T. J. (2021). Insulin-like growth factor pathway and the thyroid. Frontiers in endocrinology,12, 653627.
Yosuf, L. M. (2022). Study the correlation between thyroid disorder and chronic kidney failure. University of Thi-Qar Journal of Science, 9(2), 59-65.
Yosif, M. K., Mekki, O. J., Alrikabi, S. K. J., & Alrikabi, M. S. K. (2022). Hyperthyroidism: Demography and Clinical Criteria in Al-Nasiriyah City (2022). University of Thi-Qar Journal Of Medicine, 24(2), 127-138.
Downloads
Published
Issue
Section
License
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
